MCKMCKESSON CORP

NYSE mckesson.com


$ 543.62 $ -2.13 (-0.39 %)    

Wednesday, 08-May-2024 15:59:55 EDT
QQQ $ 439.59 $ 1.36 (0.31 %)
DIA $ 390.50 $ 1.77 (0.46 %)
SPY $ 517.10 $ -0.04 (-0.01 %)
TLT $ 90.18 $ -0.54 (-0.6 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 545.75
$ 555.00
$ 0.00 x 0
$ 0.00 x 0
$ 539.26 - $ 565.66
$ 362.61 - $ 546.63
964,634
na
73.19B
$ 0.67
$ 24.38
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-K
2 02-07-2024 12-31-2023 10-Q
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-K
6 02-02-2023 12-31-2022 10-Q
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-K
10 02-02-2022 12-31-2021 10-Q
11 11-01-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-K
14 02-02-2021 12-31-2020 10-Q
15 11-03-2020 09-30-2020 10-Q
16 08-03-2020 06-30-2020 10-Q
17 05-22-2020 03-31-2020 10-K
18 02-04-2020 12-31-2019 10-Q
19 10-30-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-K
22 01-31-2019 12-31-2018 10-Q
23 10-25-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 05-24-2018 03-31-2018 10-K
26 02-01-2018 12-31-2017 10-Q
27 10-27-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 05-22-2017 03-31-2017 10-K
30 01-26-2017 12-31-2016 10-Q
31 10-27-2016 09-30-2016 10-Q
32 07-27-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-K
34 01-27-2016 12-31-2015 10-Q
35 10-29-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-K
38 02-05-2015 12-31-2014 10-Q
39 10-28-2014 09-30-2014 10-Q
40 07-31-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-mckesson-raises-price-target-to-596

Barclays analyst Steve Valiquette maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $571 to $...

 td-cowen-maintains-buy-on-mckesson-raises-price-target-to-652

TD Cowen analyst Charles Ryhee maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $563 to $652.

 evercore-isi-group-maintains-outperform-on-mckesson-raises-price-target-to-600

Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target fr...

 ubs-maintains-buy-on-mckesson-raises-price-target-to-630

UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $620 to $630.

 baird-maintains-outperform-on-mckesson-raises-price-target-to-671

Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $603 to $671.

 mckesson-q4-2024-adj-eps-618-misses-634-estimate-sales-7640b-miss-7932b-estimate

McKesson (NYSE:MCK) reported quarterly earnings of $6.18 per share which missed the analyst consensus estimate of $6.34 by 2.52...

 how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings-report

McKesson offers a quarterly dividend amount of 62 cents per share. How can investors pocket a regular $500 monthly?

 citigroup-maintains-buy-on-mckesson-raises-price-target-to-620

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $575 to $620.

 mckinsey-faces-criminal-probe-by-doj-for-opioid-consulting-report

The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its r...

Core News & Articles

- Bloomberg

 jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

 morgan-stanley-maintains-overweight-on-mckesson-raises-price-target-to-548

Morgan Stanley analyst Erin Wright maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $522 to ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION